Exagen, Inc. (XGN)
8.17
+0.28
(+3.55%)
USD |
NASDAQ |
Oct 02, 16:00
8.14
-0.03
(-0.37%)
After-Hours: 20:00
Exagen Enterprise Value : 200.73M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 200.73M |
| October 01, 2026 | 193.95M |
| September 30, 2026 | 199.76M |
| September 29, 2026 | 203.87M |
| September 28, 2026 | 208.23M |
| September 25, 2026 | 214.03M |
| September 24, 2026 | 214.52M |
| September 23, 2026 | 209.92M |
| September 22, 2026 | 214.52M |
| September 21, 2026 | 211.61M |
| September 18, 2026 | 206.53M |
| September 17, 2026 | 193.47M |
| September 16, 2026 | 191.29M |
| September 15, 2026 | 184.27M |
| September 14, 2026 | 180.89M |
| September 11, 2026 | 173.15M |
| September 10, 2026 | 171.69M |
| September 09, 2026 | 179.92M |
| September 08, 2026 | 179.68M |
| September 04, 2026 | 186.45M |
| September 03, 2026 | 185.48M |
| September 02, 2026 | 184.76M |
| September 01, 2026 | 175.32M |
| August 31, 2026 | 180.65M |
| August 28, 2026 | 181.86M |
| Date | Value |
|---|---|
| August 27, 2026 | 185.00M |
| August 26, 2026 | 188.63M |
| August 25, 2026 | 186.94M |
| August 24, 2026 | 188.15M |
| August 21, 2026 | 194.68M |
| August 20, 2026 | 191.29M |
| August 19, 2026 | 182.82M |
| August 18, 2026 | 162.50M |
| August 17, 2026 | 165.16M |
| August 14, 2026 | 164.19M |
| August 13, 2026 | 162.26M |
| August 12, 2026 | 162.50M |
| August 11, 2026 | 166.86M |
| August 10, 2026 | 163.71M |
| August 07, 2026 | 169.27M |
| August 06, 2026 | 162.50M |
| August 05, 2026 | 163.95M |
| August 04, 2026 | 159.11M |
| August 03, 2026 | 116.29M |
| July 31, 2026 | 112.66M |
| July 30, 2026 | 116.05M |
| July 29, 2026 | 108.31M |
| July 28, 2026 | 110.73M |
| July 27, 2026 | 109.52M |
| July 24, 2026 | 116.29M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 529.32M |
| BioRestorative Therapies, Inc. | -0.8314M |
| CareDx, Inc. | 3.103B |
| Natera, Inc. | 58.08B |
| Sera Prognostics, Inc. | 38.98M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.196M |
| Revenue (Quarterly) | 19.94M |
| Total Expenses (Quarterly) | 23.14M |
| EPS Diluted (Quarterly) | -0.1323 |
| Gross Profit Margin (Quarterly) | 61.27% |
| Profit Margin (Quarterly) | -16.03% |
| Earnings Yield | -9.86% |
| Normalized Earnings Yield | -9.361 |